Vinncelas Louis

Array ( [id] => 6356576 [patent_doc_number] => 20100086995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'MHC CLASS I PEPTIDE EPITOPES FROM THE HUMAN 5T4 TUMOR-ASSOCIATED ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/501130 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17785 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086995.pdf [firstpage_image] =>[orig_patent_app_number] => 12501130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599856 [patent_doc_number] => 20100098635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'MODULAR ANTIGEN TRANSPORTER MOLECULES (MAT MOLECULES) FOR MODULATING IMMUNE REACTIONS, ASSOCIATED CONSTRUCTS, METHODS AND USES' [patent_app_type] => utility [patent_app_number] => 12/488751 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26809 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098635.pdf [firstpage_image] =>[orig_patent_app_number] => 12488751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159732 [patent_doc_number] => 20110159022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine' [patent_app_type] => utility [patent_app_number] => 13/000302 [patent_app_country] => US [patent_app_date] => 2009-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15584 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159022.pdf [firstpage_image] =>[orig_patent_app_number] => 13000302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458241 [patent_doc_number] => 20090258393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'SINGLE CHAIN CLASS I MAJOR HISTOCOMPATIBILITY COMPLEXES, CONSTRUCTS ENCODING SAME AND METHODS OF GENERATING SAME' [patent_app_type] => utility [patent_app_number] => 12/486794 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14347 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258393.pdf [firstpage_image] =>[orig_patent_app_number] => 12486794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11778202 [patent_doc_number] => 09387238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'CDCA1 epitope peptides and vaccines containing the same' [patent_app_type] => utility [patent_app_number] => 12/999051 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 13220 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703341 [patent_doc_number] => 08828403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Anti-tumor immunotherapy' [patent_app_type] => utility [patent_app_number] => 12/997630 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2278 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062245 [patent_doc_number] => 20110200626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'IQGAP3 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/997517 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18065 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200626.pdf [firstpage_image] =>[orig_patent_app_number] => 12997517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13002411 [patent_doc_number] => 10024868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy [patent_app_type] => utility [patent_app_number] => 13/377091 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7795 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110352 [patent_doc_number] => 20110189213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'MYBL2 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/997405 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12031 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189213.pdf [firstpage_image] =>[orig_patent_app_number] => 12997405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6578249 [patent_doc_number] => 20100047333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Modified Peptides and Their Use for the Treatment of Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 12/481270 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047333.pdf [firstpage_image] =>[orig_patent_app_number] => 12481270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484934 [patent_doc_number] => 20090274699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'UL16 BINDING PROTEIN 4' [patent_app_type] => utility [patent_app_number] => 12/479543 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19524 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274699.pdf [firstpage_image] =>[orig_patent_app_number] => 12479543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159725 [patent_doc_number] => 20110159021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'XBP1, CD138, AND CS1 PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/995661 [patent_app_country] => US [patent_app_date] => 2009-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 31055 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159021.pdf [firstpage_image] =>[orig_patent_app_number] => 12995661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6256886 [patent_doc_number] => 20100029571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'NOVEL AND POWERFUL MHC-CLASS II PEPTIDES DERIVED FROM SURVIVIN' [patent_app_type] => utility [patent_app_number] => 12/466222 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 38734 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029571.pdf [firstpage_image] =>[orig_patent_app_number] => 12466222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627903 [patent_doc_number] => 20100004180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Agents for the Detection and Modulation of B-Cells and Antibodies' [patent_app_type] => utility [patent_app_number] => 12/432285 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20678 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004180.pdf [firstpage_image] =>[orig_patent_app_number] => 12432285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125420 [patent_doc_number] => 20110086035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'IMMUNOTHERAPEUTIC METHODS AND MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/922132 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18002 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086035.pdf [firstpage_image] =>[orig_patent_app_number] => 12922132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367120 [patent_doc_number] => 20090304679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Antibodies as T cell receptor mimics, methods of production and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/380605 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 28126 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304679.pdf [firstpage_image] =>[orig_patent_app_number] => 12380605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533530 [patent_doc_number] => 20090233318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Methods of assaying vaccine potency' [patent_app_type] => utility [patent_app_number] => 12/380136 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25520 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233318.pdf [firstpage_image] =>[orig_patent_app_number] => 12380136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622944 [patent_doc_number] => 20100003718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'METHOD AND APPARATUS FOR THE PRODUCTION OF SOLUBLE MHC ANTIGENS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/390077 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 55611 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003718.pdf [firstpage_image] =>[orig_patent_app_number] => 12390077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9454645 [patent_doc_number] => 08715649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity' [patent_app_type] => utility [patent_app_number] => 12/322201 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 62 [patent_no_of_words] => 33743 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12322201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16743294 [patent_doc_number] => 10968269 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-04-06 [patent_title] => MHC multimers in borrelia diagnostics and disease [patent_app_type] => utility [patent_app_number] => 12/919405 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1622 [patent_figures_cnt] => 45 [patent_no_of_words] => 122339 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919405 [rel_patent_id] =>[rel_patent_doc_number] =>)